Ventyx Biosciences, Inc. (VTYX)

Ventyx Biosciences Market Cap

Ventyx Biosciences has a market cap or net worth of $258.93 million as of April 23, 2024. Its market cap has decreased by -85.10% in one year.

• Market Cap: 258.93M
• Enterprise Value: 18.24M
• 1-Year Change: -85.10%
• Ranking: #3453
• Category: Micro-Cap
• Stock Price: $4.35

Market Cap Chart

Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $258.93M, a decrease of -66.93%. That is a compound annual growth rate of -35.71%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	254.80M	-3.81%
Apr 19, 2024	264.90M	2.79%
Apr 18, 2024	257.70M	-0.69%
Apr 17, 2024	259.50M	-7.98%
Apr 16, 2024	282.00M	1.92%
Apr 15, 2024	276.70M	1.50%
Apr 12, 2024	272.60M	-
Apr 11, 2024	272.60M	-3.13%
Apr 10, 2024	281.40M	-5.76%
Apr 9, 2024	298.60M	6.76%
Apr 8, 2024	279.70M	-2.48%
Apr 5, 2024	286.80M	-1.21%
Apr 4, 2024	290.30M	-5.41%
Apr 3, 2024	306.90M	-1.16%
Apr 2, 2024	310.50M	-6.25%
Apr 1, 2024	331.20M	1.63%
Mar 28, 2024	325.90M	-5.26%
Mar 27, 2024	344.00M	-0.92%
Mar 26, 2024	347.20M	-10.40%
Mar 25, 2024	387.50M	-2.39%
Mar 22, 2024	397.00M	-8.84%
Mar 21, 2024	435.50M	-2.00%
Mar 20, 2024	444.40M	-5.06%
Mar 19, 2024	468.10M	-0.99%
Mar 18, 2024	472.80M	3.64%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Cybin	271.13M
Black Diamond Therapeutics	270.48M
GeneDx Holdings	268.09M
EDAP TMS	264.92M
Invivyd	264.67M
Prelude Therapeutics	261.60M
Sight Sciences	261.15M
Metagenomi	258.56M